These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 25399667)

  • 21. Current treatment of peripheral T-cell lymphoma.
    Horwitz SM; Coiffier B; Hsi ED; Pro B
    Clin Adv Hematol Oncol; 2011 Aug; 9(8 Suppl 16):1-15. PubMed ID: 22361915
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Diagnosis and treatment of peripheral T-cell lymphoma].
    Suzumiya J; Moriyama I; Kawakami K
    Nihon Rinsho; 2012 Apr; 70 Suppl 2():519-24. PubMed ID: 23134009
    [No Abstract]   [Full Text] [Related]  

  • 23. Hyper-CVAD chemotherapy or autologous stem cell transplantation in patients with peripheral T cell lymphomas: a single centre report.
    Xu Y; Wu XJ; Wang Y; Jin ZM; Sun AN; Wu DP
    Chin Med J (Engl); 2012 Nov; 125(22):4134-7. PubMed ID: 23158157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of clinical outcome after autologous stem cell transplantation between patients with peripheral T-cell lymphomas and diffuse large B-cell lymphoma.
    Sohn BS; Park I; Kim EK; Yoon DH; Lee SS; Kang BW; Jang G; Choi YH; Kim C; Lee DH; Kim S; Huh J; Suh C
    Bone Marrow Transplant; 2009 Sep; 44(5):287-93. PubMed ID: 19234508
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decision analysis of up-front autologous hematopoietic stem cell transplantation in patients with peripheral T-cell lymphoma.
    Fuji S; Kurosawa S; Inamoto Y; Murata T; Fuji T; Kim SW; Fukuda T
    Bone Marrow Transplant; 2019 Feb; 54(2):304-307. PubMed ID: 29795423
    [No Abstract]   [Full Text] [Related]  

  • 26. Long-term outcomes of autologous PBSCT for peripheral T-cell lymphoma: retrospective analysis of the experience of the Fukuoka BMT group.
    Numata A; Miyamoto T; Ohno Y; Kamimura T; Kamezaki K; Tanimoto T; Takase K; Henzan H; Kato K; Takenaka K; Fukuda T; Harada N; Nagafuji K; Teshima T; Akashi K; Harada M; Eto T;
    Bone Marrow Transplant; 2010 Feb; 45(2):311-6. PubMed ID: 19597416
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Allogeneic transplantation following a reduced-intensity conditioning regimen in relapsed/refractory peripheral T-cell lymphomas: long-term remissions and response to donor lymphocyte infusions support the role of a graft-versus-lymphoma effect.
    Dodero A; Spina F; Narni F; Patriarca F; Cavattoni I; Benedetti F; Ciceri F; Baronciani D; Scimè R; Pogliani E; Rambaldi A; Bonifazi F; Dalto S; Bruno B; Corradini P
    Leukemia; 2012 Mar; 26(3):520-6. PubMed ID: 21904377
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of high-dose therapy and stem cell rescue in the management of T-cell malignant lymphomas: a BSBMT and ABMTRR study.
    Feyler S; Prince HM; Pearce R; Towlson K; Nivison-Smith I; Schey S; Gibson J; Patton N; Bradstock K; Marks DI; Cook G
    Bone Marrow Transplant; 2007 Sep; 40(5):443-50. PubMed ID: 17589529
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improving therapy for patients with aggressive lymphoma.
    Armitage JO
    Transfus Apher Sci; 2011 Apr; 44(2):179-82. PubMed ID: 21345733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Treatment outcome and prognosis of autologous hematopoietic stem cell transplantation combined with high dose radiotherapy/chemotherapy in 22 patients with nasal NK/T cell lymphoma].
    Cui XZ; Wang HQ; Liu XM; Zhang HL; Li W
    Zhonghua Xue Ye Xue Za Zhi; 2007 Sep; 28(9):609-11. PubMed ID: 18246818
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T-cell lymphoma.
    Lennard A
    Br J Haematol; 2007 Apr; 137(2):170; author reply 171. PubMed ID: 17391498
    [No Abstract]   [Full Text] [Related]  

  • 32. Successful treatment of a child with late-onset T-cell post-transplant lymphoproliferative disorder/lymphoma.
    Williams KM; Higman MA; Chen AR; Schwartz CL; Wharam M; Colombani P; Arceci RJ
    Pediatr Blood Cancer; 2008 Mar; 50(3):667-70. PubMed ID: 17318876
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous stem cell transplantation as the first-line treatment for peripheral T cell lymphoma: results of a comprehensive meta-analysis.
    Yin J; Wei J; Xu JH; Xiao Y; Zhang YC
    Acta Haematol; 2014; 131(2):114-25. PubMed ID: 24158006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Combination chemotherapy followed by autologous stem cell transplant for enteropathy-associated T cell lymphoma.
    Bishton MJ; Haynes AP
    Br J Haematol; 2007 Jan; 136(1):111-3. PubMed ID: 17116129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tale of two lymphomas: peripheral T-cell lymphoma after allogeneic stem-cell transplantation for marginal zone lymphoma.
    Lee L; Lipton JH; Bailey D; Kukreti V
    J Clin Oncol; 2012 Nov; 30(31):e309-11. PubMed ID: 22965958
    [No Abstract]   [Full Text] [Related]  

  • 36. High dose chemotherapy and autologous stem cell transplantation in patients with peripheral T-cell lymphoma not achieving complete response after induction chemotherapy. The GEL-TAMO experience.
    Rodriguez J; Caballero MD; Gutierrez A; Gandarillas M; Sierra J; Lopez-Guillermo A; Sureda A; Zuazu J; Marin J; Arranz R; Carreras E; Leon A; De Sevilla AF; San Miguel JF; Conde E;
    Haematologica; 2003 Dec; 88(12):1372-7. PubMed ID: 14687990
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
    Hagemeister FB
    Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
    [TBL] [Abstract][Full Text] [Related]  

  • 38. DexaBEAM versus ICE salvage regimen prior to autologous transplantation for relapsed or refractory aggressive peripheral T cell lymphoma: a retrospective evaluation of parallel patient cohorts of one center.
    Mikesch JH; Kuhlmann M; Demant A; Krug U; Thoennissen GB; Schmidt E; Kessler T; Schliemann C; Pohlen M; Mohr M; Evers G; Köhler G; Wessling J; Mesters R; Müller-Tidow C; Berdel WE; Thoennissen NH
    Ann Hematol; 2013 Aug; 92(8):1041-8. PubMed ID: 23532626
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Allogeneic stem cell transplantation is able to induce long-term remissions in angioimmunoblastic T-cell lymphoma: a retrospective study from the lymphoma working party of the European group for blood and marrow transplantation.
    Kyriakou C; Canals C; Finke J; Kobbe G; Harousseau JL; Kolb HJ; Novitzky N; Goldstone AH; Sureda A; Schmitz N
    J Clin Oncol; 2009 Aug; 27(24):3951-8. PubMed ID: 19620487
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Peripheral T-cell lymphoma: autologous hematopoietic cell transplantation as first-line therapy.
    Laport GG
    Curr Opin Oncol; 2010 Sep; 22(5):409-13. PubMed ID: 20683269
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.